Cohen R A
J Clin Invest. 1985 Jan;75(1):286-92. doi: 10.1172/JCI111687.
The purpose of this study was to determine if 5-hydroxytryptamine released from aggregating platelets could be accumulated and released by canine coronary adrenergic nerves, and if the false neurotransmitter resulted in an abnormal response of the smooth muscle to nerve stimulation. Isometric tension was measured in rings of epicardial coronary suspended in organ chambers filled with physiological salt solution. The response to electrical stimulation or exogenously added norepinephrine was elicited after contraction with prostaglandin F2 alpha. Electrical stimulation and exogenous norepinephrine caused beta-adrenergic relaxation of control rings. However, after rings were exposed for 2 h to aggregating platelets or 5-hydroxytryptamine, electrical stimulation caused frequency-dependent contractions. These contractions were prevented by the serotonergic antagonists, cyproheptadine or ketanserin, or by the neuronal uptake inhibitor, cocaine. The relaxation caused by exogenously added norepinephrine was unchanged after exposure to platelets or 5-hydroxytryptamine, indicating that smooth muscle alpha- and beta-adrenergic responsiveness was unchanged. The electrically stimulated overflow of radiolabeled norepinephrine from superfused strips of coronary artery was not altered by prior exposure to 5-hydroxytryptamine, indicating that the effect of exposure on the response to electrical stimulation is primarily at smooth muscle serotonergic receptors. Canine coronary arteries accumulated and metabolized radiolabeled 5-hydroxytryptamine in vitro. The accumulation of 5-hydroxytryptamine was inhibited by cocaine or by adrenergic denervation with 6-hydroxydopamine but unaffected by removal of endothelium, indicating that the adrenergic nerves were the primary site of accumulation. Electrical stimulation of superfused strips of coronary artery preincubated with radiolabeled 5-hydroxytryptamine caused the release of the intact indoleamine; this was blocked by the neurotoxin, tetrodotoxin. These studies suggest that 5-hydroxytryptamine liberated from aggregating platelets may be accumulated by coronary adrenergic nerve endings. Upon its release from the nerves as a false transmitter, the amine can activate serotonergic receptors on the smooth muscle and reverse the action of the adrenergic nerves from dilator to constrictor.
本研究的目的是确定聚集血小板释放的5-羟色胺是否能被犬冠状动脉肾上腺素能神经摄取并释放,以及这种假神经递质是否会导致平滑肌对神经刺激产生异常反应。在充满生理盐溶液的器官浴槽中,测量悬吊的心外膜冠状动脉环的等长张力。在用前列腺素F2α收缩后,引发对电刺激或外源性添加去甲肾上腺素的反应。电刺激和外源性去甲肾上腺素引起对照环的β-肾上腺素能舒张。然而,在冠状动脉环暴露于聚集血小板或5-羟色胺2小时后,电刺激引起频率依赖性收缩。这些收缩可被5-羟色胺能拮抗剂赛庚啶或酮色林,或被神经元摄取抑制剂可卡因所抑制。暴露于血小板或5-羟色胺后,外源性添加去甲肾上腺素引起的舒张没有改变,表明平滑肌α-和β-肾上腺素能反应性没有改变。预先暴露于5-羟色胺不会改变放射性标记的去甲肾上腺素从冠状动脉条带的电刺激溢出,表明暴露对电刺激反应的影响主要作用于平滑肌5-羟色胺能受体。犬冠状动脉在体外能摄取并代谢放射性标记的5-羟色胺。可卡因或用6-羟基多巴胺进行肾上腺素能去神经支配可抑制5-羟色胺的摄取,但去除内皮对其无影响,表明肾上腺素能神经是摄取的主要部位。对预先用放射性标记的5-羟色胺孵育的冠状动脉条带进行电刺激,可导致完整吲哚胺的释放;这被神经毒素河豚毒素所阻断。这些研究表明,聚集血小板释放的5-羟色胺可能被冠状动脉肾上腺素能神经末梢摄取。当该胺作为假神经递质从神经释放时,它可激活平滑肌上的5-羟色胺能受体,并使肾上腺素能神经的作用从舒张转为收缩。